Connection

David Neskey to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications David Neskey has written about Cyclin-Dependent Kinase Inhibitor p16.
David Neskey
Connection Strength
0.049
Cyclin-Dependent Kinase Inhibitor p16
  1. Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.